Selective replication of diplophage Dp-4 deoxyribonucleic acid in 6-(p-hydroxyphenylazo)-uracil treated Streptococcus pneumoniae.
D001435:Bacteriophages / Q000187:drug effects / Q000378:metabolism*; D004261:DNA Replication / Q000187:drug effects*; D004269:DNA, Bacterial / Q000096:biosynthesis*; D004279:DNA, Viral / Q000096:biosynthesis*; D005467:Floxuridine / Q000494:pharmacology; D006906:Hydroxyphenylazouracil / Q000494:pharmacology*; D006918:Hydroxyurea / Q000494:pharmacology; D007700:Kinetics; D009268:Nalidixic Acid / Q000494:pharmacology; D013296:Streptococcus pneumoniae / Q000187:drug effects / Q000378:metabolism*; D014498:Uracil / Q000031:analogs & derivatives*; D014779:Virus Replication / Q000187:drug effects*
D004269:DNA, Bacterial; D004279:DNA, Viral; D005467:Floxuridine; D006906:Hydroxyphenylazouracil; D009268:Nalidixic Acid; D014498:Uracil; D006918:Hydroxyurea